Oncodesign News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncodesign. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncodesign Today - Breaking & Trending Today

Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023

Nomination of Florence Dupré as a member of the Board of Directors Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing ....

Mathilde Bohin Alban Dufumier , Fondation Universit , Florence Dupr , Philippe Genne , Arthur Rouill , Karine Lignel , Vifor Pharma , Bioalliance Pharma , Le Figaro , International Women Rights Day , Committee Of The Syndicat National Des Technologies , Expressions De France Association , Precision Medicine , General Meeting , Normale Sup , Executive Committee , Management Board , Les Echos , International Women , Board Ready , Oncodesign Precision Medicine , Chief Executive Officer , Bohin Alban Dufumier , Gefallene Big Techs ,

Oncodesign Precision Medicine: OPM Announces Its 2022 Annual Results and Provides an Update on Its Clinical Developments

Revenues and operating income in 2022 of €8.3 M (+110% vs. 2021 proforma), including revenues of €8 M, mainly driven by a €7 M milestone and a €0.5 M up-front Net income almost at break-even ....

Arthur Rouill , Jan Hoflack , Karine Lignel , Philippe Genne , Mathilde Bohin Alban Dufumier , Research Tax Credit , Oncodesign Services , Transition Service Agreement , Precision Medicine , Chief Executive Officer , Oncodesign Biotechnology , Euronext Growth , Artificial Intelligence , Monday April , Ordinary General Meeting , Oncodesign Precision Medicine , Bohin Alban Dufumier ,

Oncodesign Precision Medicine: Publication of the 2023 Financial Calendar

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnémonique: ALOPM) (Paris:ALOPM),a biopharmaceutical company specializing in precision medicine for the treatment of resistant ....

France General , Arthur Rouill , Mathilde Bohin Alban Dufumier , Philippe Genne , Schwierige Zeiten , Regulatory News , Precision Medicine , General Meeting , Half Results , Oncodesign Precision Medicine , Bohin Alban Dufumier ,

Oncodesign Precision Medicine (OPM) Announces its IPO Through Direct Listing on Euronext Access + Paris

Direct listing of OPM on Euronext Access Paris on 5 October 2022 Q&A available (only in French): click here Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; ....

France General , Arthur Rouill , Mathilde Bohin , Philippe Genne , Euronext Access Paris , Precision Medicine , Euronext Paris , Euronext Access , Euronext Growth , Oncodesign Precision Medicine , Mrs Catherine , Mrs Aliz ,

The General Meeting of Oncodesign Authorises the Allocation of Oncodesign Precision Medicine (OPM) Shares to Oncodesign Shareholders

Each Oncodesign shareholder will receive one OPM share for one ONCODESIGN share held Regulatory News: Oncodesign's (Paris:ALONC) General Meeting held on September 30, 2022, authorised the ....

Arthur Rouill , Mathilde Bohin , Philippe Genne , Each Oncodesign , General Meeting , Euronext Access , Oncodesign Precision Medicine , Precision Medicine , Euronext Growth Market , Artificial Intelligence , Oncodesign Precision Medicine ,